Elevance Health (XTER:A58) Cash Flow for Dividends: €-1,306 Mil (TTM As of Mar. 2026)


XTER:A58 Elevance Health Inc XTER:A58
89 GF Score
Price €343.40
GF Value €441.91
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Elevance Health Cash Flow for Dividends?

Elevance Health XTER:A58 +1.21% 89 Cash Flow for Dividends is €-1,306 Mil as of Mar. 2026. GuruFocus rates XTER:A58 with a GF Score™ of 89/100 and a GF Value™ of €441.91 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Elevance Health's cash flow for dividends for the three months ended in Mar. 2026 was €-325 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was €-1,306 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Elevance Health's quarterly payment of dividends declined from Sep. 2025 (€-325 Mil) to Dec. 2025 (€-322 Mil) but then increased from Dec. 2025 (€-322 Mil) to Mar. 2026 (€-325 Mil).

Elevance Health's annual payment of dividends increased from Dec. 2023 (€-1,279 Mil) to Dec. 2024 (€-1,440 Mil) but then declined from Dec. 2024 (€-1,440 Mil) to Dec. 2025 (€-1,306 Mil).

Elevance Health Cash Flow for Dividends Related Terms

Elevance Health Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Elevance Health's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elevance Health Cash Flow for Dividends Chart

Elevance Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -977.04 -1,160.18 -1,279.22 -1,440.14 -1,305.77

Elevance Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -357.05 -333.80 -324.61 -321.96 -325.24
XTER:A58
89GF Score
Elevance Health Inc XTER:A58
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Elevance Health Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1,306 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of €-1,306 Mil mean?
Elevance Health (XTER:A58) has a Cash Flow for Dividends of €-1,306 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Elevance Health and its competitors.
Is Elevance Health's Cash Flow for Dividends too high?
Elevance Health's current Cash Flow for Dividends is €-1,306 Mil. Overall, Elevance Health has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Elevance Health's Cash Flow for Dividends compare to CI and CVS?
Elevance Health's Cash Flow for Dividends of €-1,306 Mil can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Healthcare Plans company?
A good Cash Flow for Dividends depends on the Healthcare Plans industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Elevance Health and its competitors. Elevance Health's current Cash Flow for Dividends is €-1,306 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elevance Health stock overvalued right now?
Based on GuruFocus' analysis, Elevance Health (XTER:A58) is currently considered Modestly Undervalued. The stock's GF Value™ is €441.91, compared to a current price of €343.40 — trading 22.3% below its estimated fair value. The current Cash Flow for Dividends is €-1,306 Mil. Elevance Health's overall GF Score™ is 89/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Elevance Health (XTER:A58), the current Cash Flow for Dividends is €-1,306 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Elevance Health (XTER:A58) Overvalued in 2026?

Based on GuruFocus' analysis, Elevance Health stock appears to be undervalued. The current stock price of €343.40 is trading 22.3% below its estimated GF Value™ of €441.91. GuruFocus considers Elevance Health to be Modestly Undervalued.

Key valuation signals for XTER:A58:

  • Cash Flow for Dividends: €-1,306 Mil
  • GF Value™: €441.91 vs. price of €343.40 (22.3% below fair value)
  • GF Score™: 89/100 with 7 warning signs

No single metric tells the full story. See the XTER:A58 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Elevance Health Business Description

Address 220 Virginia Avenue, Indianapolis, IN, USA, 46204
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
89GF Score

Get the complete analysis for XTER:A58

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€343.40
Price
€441.91
GF Value